Ensign Peak Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $400M | Buy |
2,154,006
+31,590
| +1% | +$5.86M | 0.68% | 21 |
|
|
2025
Q1 | $445M | Buy |
2,122,416
+63,027
| +3% | +$13.2M | 0.85% | 18 |
|
|
2024
Q4 | $366M | Buy |
2,059,389
+29,697
| +1% | +$5.28M | 0.65% | 25 |
|
|
2024
Q3 | $401M | Sell |
2,029,692
-44,209
| -2% | -$8.73M | 0.7% | 23 |
|
|
2024
Q2 | $356M | Sell |
2,073,901
-28,733
| -1% | -$4.93M | 0.65% | 27 |
|
|
2024
Q1 | $383M | Buy |
2,102,634
+127,034
| +6% | +$23.1M | 0.7% | 22 |
|
|
2023
Q4 | $306M | Sell |
1,975,600
-360,985
| -15% | -$55.9M | 0.61% | 34 |
|
|
2023
Q3 | $348M | Buy |
2,336,585
+525,155
| +29% | +$78.3M | 0.74% | 26 |
|
|
2023
Q2 | $244M | Sell |
1,811,430
-727,009
| -29% | -$97.9M | 0.49% | 48 |
|
|
2023
Q1 | $405M | Sell |
2,538,439
-331,094
| -12% | -$52.8M | 0.88% | 19 |
|
|
2022
Q4 | $464M | Buy |
2,869,533
+35,399
| +1% | +$5.72M | 1.04% | 13 |
|
|
2022
Q3 | $380M | Sell |
2,834,134
-842,306
| -23% | -$113M | 0.94% | 18 |
|
|
2022
Q2 | $563M | Buy |
3,676,440
+326,206
| +10% | +$50M | 1.34% | 8 |
|
|
2022
Q1 | $543M | Buy |
3,350,234
+623,629
| +23% | +$101M | 1.1% | 11 |
|
|
2021
Q4 | $369M | Buy |
2,726,605
+474,301
| +21% | +$64.2M | 0.71% | 25 |
|
|
2021
Q3 | $243M | Buy |
2,252,304
+530,612
| +31% | +$57.2M | 0.51% | 41 |
|
|
2021
Q2 | $194M | Buy |
1,721,692
+107,162
| +7% | +$12.1M | 0.39% | 70 |
|
|
2021
Q1 | $175M | Buy |
1,614,530
+56,783
| +4% | +$6.15M | 0.38% | 72 |
|
|
2020
Q4 | $167M | Buy |
1,557,747
+701,069
| +82% | +$75.1M | 0.38% | 62 |
|
|
2020
Q3 | $75M | Buy |
856,678
+156,569
| +22% | +$13.7M | 0.19% | 104 |
|
|
2020
Q2 | $68.7M | Buy |
700,109
+322,921
| +86% | +$31.7M | 0.19% | 100 |
|
|
2020
Q1 | $28.7M | Sell |
377,188
-102,289
| -21% | -$7.79M | 0.1% | 161 |
|
|
2019
Q4 | $42.5M | Buy |
+479,477
| New | +$42.5M | 0.11% | 151 |
|